The Approval Process in Action

Source: The Life Sciences Report and Visual Capitalist (5/1/13)

What catalysts in the drug development process move biotech company stocks? The savvy investor must know what steps in the U.S. Food and Drug Administration's approval process can propel a stock up or down. From drug discovery to the much-anticipated PDUFA date, The Life Sciences Report and the Visual Capitalist have collaborated on an infographic that describes both the process and related catalysts.

For news on how catalysts affect specific stocks, read the updated Life Sciences Report Watchlist.

3D Model Redraws Historic Mining Camp as Land Position Surges to District Scale
Source: Streetwise Reports (02/09/2026)

ESGold Corp. (ESAU:CSE; ESAUF:OTCQB; Z7D:FSE) expanded its Montauban land position in Quebec by staking 144 new claims, bringing total holdings to 417 claims across 20,618 hectares. The move followed a 3D geological model identifying mineralization extending to roughly 900 meters depth and more than two kilometers of strike.

Silver Junior Finds Breccia Zone Breakthrough at Mexico's Dios Padre
Source: Streetwise Reports (02/09/2026)

The second hole of Regency Silver Corp.'s (RSMX:TSX.V; RSMXF:OTCQB) ongoing 2026 drilling program at its Dios Padre project in Sonora, Mexico, intersected sulfide-specularite-bearing breccia and vein-infill across multiple zones within a broad interval. Read how one technical analyst rates the stock.

High-Grade Gold Hits in New Footwall Zones as Drilling Extends a 600-Meter Trend
Source: Streetwise Reports (02/09/2026)

Dryden Gold Corp. (DRY:TSXV; DRYGF:OTCQB; X7W:FSE) reported new drill results from the Pearl zone at its Gold Rock Target Area, including the first significant footwall mineralization identified at Pearl. The results included multiple near-surface high-grade intercepts and confirmed additional stacked mineralized zones along the Elora shear structure.

Experts Spotlight a Persistent Barrier in Advanced Cancer Therapies
Source: Streetwise Reports (02/09/2026)

Rakovina Therapeutics Inc. (RKV:TSX.V) outlined its AI-driven approach to brain-penetrant ATR and mTOR inhibitors during the 9th Annual DNA Damage Response Inhibitors Summit in Boston. The company also reported inbound interest in its kt-3000 series as potential payloads for antibody-drug conjugates.

Copper Explorer Finds Massive 41.6m Multi-Horizon Skarn Breakthrough in Mexico
Source: Streetwise Reports (02/09/2026)

Algo Grande Copper Corp. (ALGR:TSX.V) announces initial drill results from its first drilling program at the Adelita Project in Sonora, Mexico. Find out how one technical analyst rates the stock.